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Background: Inflammatory breast cancer (IBC) is the most aggressive form of breast cancer characterized by
invasion of carcinoma cells into dermal lymphatic vessels where they form tumor emboli over expressing adhesion
molecule E-cadherin. Although invasion and metastasis are dynamic processes controlled by complex interaction
between tumor cells and microenvironment the mechanisms by which soluble mediators may regulate motility
and invasion of IBC cells are poorly understood. The present study investigated the effect of media conditioned by
human monocytes U937 secreted cytokines, chemokines and growth factors on the expression of adhesion
molecules E-cadherin and fibronectin of human IBC cell line SUM149. Furthermore, cytokines signaling pathway
involved were also identified.
Results: U937 secreted cytokines, chemokines and growth factors were characterized by cytokine antibody array.
The major U937 secreted cytokines/chemokines were interleukin-8 (IL-8) and monocyte chemotactic protein-1
(MCP-1/CCL2). When SUM149 cells were seeded in three dimensional (3D) models with media conditioned by
U937 secreted cytokines, chemokines and growth factors; results showed: 1) changes in the morphology of IBC
cells from epithelial to migratory spindle shape branched like structures; 2) Over-expression of adhesion molecule
fibronectin and not E-cadherin. Further analysis revealed that over-expression of fibronectin may be mediated by
IL-8 via PI3K/Akt signaling pathway.
Conclusion: The present results suggested that cytokines secreted by human monocytes may promote
chemotactic migration and spreading of IBC cell lines. Results also indicated that IL-8 the major secreted cytokine
by U937 cells may play essential role in fibronectin expression by SUM149 cells via interaction with IL-8 specific
receptors and stimulation of PI3K/Akt signaling pathway.
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Background
Inflammatory breast cancer (IBC) is the most lethal
form of breast cancer associated with particularly
aggressive behavior and poor prognosis in young
women [1]. IBC is pathologically defined as invasive
adenocarcinoma, where carcinoma cells possess high
metastatic properties and ability to invade lymphatic
vessels of breast stroma and skin forming tumor emboli
[2]. Spreading of tumor emboli within lymphatic and
blood vessels leads to distant metastasis and multi-organ
failure in IBC patients [3].
Alterations in the expression of adhesion molecules
such as the epithelial marker E-cadherin and the
mesenchymal marker fibronectin [4] were found to play
a crucial role in the progression of breast cancer
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any medium, provided the original work is properly cited.metastasis [5-7]. IBC is characterized by over-expression
of E-cadherin, a cell surface adhesion protein which
mediates cell-cell contact [8]. Loss of E-cadherin in pri-
mary breast carcinoma was associated with disease poor
prognosis [9]. Paradoxically, E-cadherin over-expression
in IBC contributes to disease aggressiveness and low
survival rate [8] since, E-cadherin expression by IBC
carcinoma cells allows cell to cell adhesion and the for-
mation of tumor emboli within the lymphatic vessels
[10,11]. Moreover, the process of invasion and dissemi-
nation of IBC tumor emboli is mediated by expression
of E-cadherin and the activity of matrix metalloprotei-
nases (MMP-1 and MMP-9) [12]. E-cadherin has also
been reported to be involved in different cellular biolo-
gical processes including cell growth [13] and differen-
tiation [14]. Furthermore, IBC cell lines SUM149 were
found to express mesenchymal extracellular matrix
(ECM) glycoprotein fibronectin [15] an adhesion mole-
cule involved in cell-cell and cell-matrix adhesion [16].
Fibronectin is also associated with cell differentiation,
oncogenic transformation, motility and migration [16].
For example, studies demonstrated that fibronectin
increases the secretion of matrix metalloproteinase-9
(MMP-9) in ovarian cancer and stimulate the growth of
non-small cell lung carcinoma via PI3K/Akt signaling
pathway [17,18]. Interestingly, PI3K/Akt pathways found
to induce fibronectin expression assuming a reciprocal
stimulation of fibronectin production via PI3K/Akt path-
way [19,20]
One of the limitations in understanding IBC biology
may be due to the lack of an in-vitro culture model that
simulates in-vivo tumor microenvironment. Studies
showed that mammary tumor cells grown in monolayer
or 2 dimensional (2D) culture exhibited different physio-
logical and molecular properties than those grown in 3
dimensional (3D) cultures [21]. The in vitro 3D culture
provides mammary epithelial cells with basement mem-
brane-like matrices that mimic in vivo growth. Growing
cells in 3D models allow cell-matrix interactions that
reorganize and modulate cytoskeleton, chromatin struc-
ture and cell polarity [22-24]. Furthermore, 3D culture
can preserve cell physiological functions which cannot
be carried out in monolayer culture. For example, mam-
mary epithelial cells grown on 3D model produce casein
[25] and hepatocytes can synthesize cytochrome P450
[26]. Focusing on the application of 3D culture models
on breast cancer research there are various studies by
Bissell and her collaborators showing that 3D cell cul-
ture assays could be used to study mechanisms for mor-
phogenesis, gene/protein expression profiles and
neoplasia of human breast in vitro [27-29]. For instance,
Bissel and her colleagues compared the morphological
phenotype and gene expression profile of 25 breast can-
cer cell lines seeded in monolayer and in 3D culture.
Their results showed that breast cancer cell lines cul-
tured in 3D form “colonies” that could be morphologi-
cally divided into four groups: round, mass, grape like
and stellate [29]. Moreover, gene expression profile and
signal transduction pathways were different among cells
when cultured in 3D versus monolayer culture [29].
Using in vitro 3D models Hoffmeyer and colleagues
compared the growth of IBC cell line SUM149 and non-
IBC cell line SUM102 as control (since it shares
SUM149 loss in inflammatory breast cancer gene) [30].
The SUM149 cells showed an increase in expression of
Rho A and E-cadherin proteins and more adhesion to
collagen I than SUM102. Over-expression of RhoA and
E-cadherin may promote cell to cell adhesion which is
essential for passive metastasis by IBC tumor emboli
[30].
Dissemination of carcinoma cells is modulated by
adhesion molecules, which may be affected by different
factors including cues from inflammatory cells within
the tumor microenvironment [31]. Monocytes/macro-
phages are the major inflammatory cells constituting
breast tumor microenvironment [32,33] and contribut-
ing to high levels of growth factors, hormones, and cyto-
kines [34,35]. Monocytes/macrophages secreted
cytokines, chemokines and growth factors were found to
induce the migration, invasion, and metastasis of carci-
noma cells [36,37]. Furthermore, monocytes/macro-
phages secretions found to alter the expression of
adhesion molecules fibronectin and E-cadherin. For
instance, TNF-a,I L - 1 b,a n dI L - 6 ,s e c r e t e db ym o n o -
cytes/macrophages were shown to modulate the expres-
sion of fibronectin by primary keratinocytes in 3D tissue
culture models [38]. Similarly TNF-a was found to
modulate expression of E-cadherin by bronchial epithe-
lial cells [19]. On the other hand, oncostatin M released
by activated mononuclear cells increased the expression
of fibronectin and decreased the expression of E-cad-
herin by myofibroblasts [39]. A recent study demon-
strated that interaction of IL-8 with its specific receptors
CXCR1 and CXCR2 induce fibronectin expression
essential for epithelial mesnchymal transition and moti-
lity of human breast carcinoma cells [40]. Thus, mono-
cytes/macrophages secreted cytokines, chemokines and
growth factors may modulate the expression of adhesion
molecules E-cadherin and fibronectin by different cell
lines.
In a previous study by Mohamed and colleagues, co-
culture of SUM149 cells with U937 cells or in U937-
conditioned media (U937-CM) in 3D tissue culture
model increased invasiveness, motility and proteolytic
activity of SUM149 cells [41]. Herein, the study aimed
to identify secreted cytokines, chemokines and growth
factors in U937-CM and to utilize 3D model to test
whether invasion and motility of SUM149 in response
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cules E-cadherin and fibronection. Results indicated that
U937-CM enhances the motility and spreading of
SUM149 cells by increasing fibronectin expression.
Moreover, IL-8 a major cytokine secreted by U937 cells
found to be involved in fibronectin expression via sti-
mulating PI3K/Akt signaling pathway.
Results
Formation of emboli like structure by SUM149 cells when
grown on 3D culture model
The basic principle of 3D cell cultures is to provide
mammary carcinoma cells with properties that recapitu-
late in-vivo tumor microenvironment. The 3D cellular
structures were characterized by establishment of adhe-
sion complexes, tissue polarity, cytoskeletal structures,
and cell volume that is significantly different from those
found in traditional monolayer culture [24,42].
Alteration in the morphology of SUM149 grown on
monolayer versus those grown on 3D models were
observed after 24 h, 48 h and 72 h. SUM149 cells grown
on monolayer adhere to plastic surface after 24 h (Figure
1A, left panel). SUM149 cells form projections towards
each other after 48 h (Figure 1A, middle panel) and
divide to 70-80% confluence after 72 h (Figure 1A, right
panel). On the other hand, SUM149 cells grown on 3D
model became connected together after 24 h (Figure 1B,
left panel) and formed aggregates after 48 h (Figure 1B,
middle panel). Clumps of cells simulate in-vivo emboli
like structures were observed after 72 h (Figure 1B, right
panel). The morphology acquired by SUM149 cells when
seeded in-vitro in 3D culture model resembles in vivo
tumor emboli of IBC patients (Figure 1C) where IBC car-
cinoma cells adhered together forming clusters sur-
rounded by endothelial cells and basement membrane
[10,11]. The adherence of IBC cells within lymphatic ves-
sels forming tumor emboli was assumed to be attributed
to over-expression of E-cadherin [8].
Cytokines profile of human monocytes U937 conditioned
media (U937-CM)
Using cytokine antibody array analysis cytokines, che-
mokines and growth factors secreted by U937 were
identified in U937-CM. Cytokine antibody array
detected difference in density values of the assessed
cytokines, chemokines and growth factors (Figure 2A).
Densitometry analysis performed with ImageJ software
showed that cytokines, chemokines and growth factors
of low density value (0-4000) were: IL-7, IL-3, MCP-2,
GCSF, GM-CSF, IL-17, IL-6, IL-12p70, MIG, ICAM-1,
IL-2, IL-16, Eotaxin, IL-4, IL-13, IL-15, IL-1b, IL-11,
TGF-b, MIP-1δ, IFN-g, sTNFRI, I-309, TNf-b, IL-12p40,
IL-1a,P D G F - B B ,E o t a x i n - 2 ,M I P - 1 a,I P - 1 0 ,a n dI L - 1 0 ,
respectively. Cytokines, chemokines and growth factors
of moderate density values (4001-8000) were: IL-6sR,
M-CSF, sTNFRII, MIP-1b,T N F - a, RANTES and TIMP-
2, respectively, while cytokines and chemokine of high
density value (> 8000) were IL-8 and MCP-1 (CCL2)
(Figure 2B).
U937-CM induced the expression of adhesion molecule
fibronectin by SUM149 cells in 3D tissue culture models
Results revealed that U937-CM induced the migration
and formation of branched like structures by SUM149
cells; which was consistent with previous results of the
author and colleagues [41]. The level of expression of E-
cadherin by SUM149 cells grown in U937-CM, for 48 h
at 37°C in humidified CO2 incubator, in comparison to
control ones grown in complete Ham’sF - 1 2m e d i a
under same conditions was measured by immunoblot.
The expression of E-cadherin was not altered by control
SUM149 cells grown in complete Ham’sF - 1 2m e d i a
compared to SUM149 cells grown in U937-CM (Figure
3A). Immunocytochemistry confirmed immunoblot
results which showed no difference in the level of
expression of E-cadherin by control SUM149 cells
grown in complete Ham’s F-12 media (Figure 3B) when
compared to SUM149 cells grown in U937-CM (Figure
3C).
On the other hand immunoblot analysis showed that
the adhesion molecule fibronectin, which is responsible
for cell-cell and cell-matrix interaction was weakly
expressed by control SUM149 cells grown in complete
Ham’s F-12 media and over-expressed by SUM149 cells
grown in U937-CM for 48 h in 3D culture model (Fig-
ure 4A). Similarly, immunocytochemical staining of
fibronectin revealed a weak expression of cellular and
membranous fibronectin by control SUM149 cells
g r o w ni nc o m p l e t eH a m ’s F-12 media (Figure 4B) com-
pared to SUM149 cells grown in U937-CM for 48 h in
3D culture model at 37°C in CO2 incubator (Figure 4C).
IL-8 signaling pathway is involved in fibronectin
expression by SUM149 cells
Treatment of SUM149 cells with recombinant MCP-1
and IL-8 induced the expression of fibronectin by
SUM149 cells as detected by immunoblot analysis (Fig-
ure 5A). Since, PI3K/Akt signaling molecules found to
be involved in fibronectin expression [19,20] the level of
expression of PI3K, Akt and p-Akt in SUM149 cells
treated with recombinant IL-8 and MCP-1 were mea-
sured. Immunoblot results showed that IL-8 induced the
expression of PI3K-p85, total Akt and p-Akt by
SUM149 cells. On the contrary, MCP-1 did not alter
the level of expression of the PI3K/Akt signaling mole-
cules by SUM149 cells (Figure 5A).
Since the physiological effects of IL-8 are mediated by its
specific receptors CXCR1 and CXCR2, the expression of
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Figure 1 Alteration in the morphology of SUM149 cells cultured in monolayer versus 3D culture models. A) SUM149 cells grown on
monolayer culture for 24 h showing cells adhering to monolayer (left panel). SUM149 cells divided and became attached to each other after 48
h (middle panel) reaching 80% confluent after 72 h as shown in 9 fields’ image (right panel. Nuclei were stained with blue stain DAPI. B)
SUM149 cells grown in 3D overlay culture cells form aggregates after 24 h (left panel), divide and form connected like structures after 48 h
(middle panel). After 72 h cell division increased and SUM149 cells formed emboli like structures which were distributed all over 3D culture
model shown in 9 fields image (right panel) nuclei stained with blue stain DAPI were distributed within the tumor emboli structures, (scale bar
=2 0μm). C) Archival H&E stain of paraffin embedded tissue section of IBC patient sample showing IBC cells invasion into blood and lymphatic
vessels forming tumor emboli while tumor cells strongly bound together and retracted away from surrounding endothelial lining. Results were
representatives of 3 independent experiments.
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immunoblot. Results revealed that SUM149 cells express
CXCR1 and CXCR2 regardless the treatment of MCP-1
and IL-8 (Figure 5B). The present results are consistent
with other studies which showed that IL-8 specific recep-
tors CXCR1 and CXCR2 may regulate fibronectin expres-
sion through PI3k/Akt pathway [40,43].
Discussion
Adhesion molecules E-cadherin and fibronectin are hall-
marks of epithelial mesenchymal transition (EMT), cancer
invasion and motility [44]. E-cadherin expression by breast
carcinoma cells was found to be regulated epigenetically
via hypermethylation of the promoter region which pro-
vides cancer cell with flexibility to switch between EMT at
primary tumor site and mesenchymal epithelial reverting
transition (MErT) at the site of metastasis [9]. Reversion
from epithelial to mesnchymal type at the site of metasta-
sis depends on signals from the tumor microenvironment
[7]. Studies postulated that IBC cells disseminate as a clus-
ter of cells adhered together by adhesion molecule E-cad-
herin resulting in vascular blocking and organ failure
leading to more aggressiveness of the disease [3]. On the
other hand, adhesion molecule fibronectin is a mesenchy-
mal marker regulating cell-cell and cell-matrix interac-
tions. Fibronectin has been identified to be responsible for
formation of branched like structures of salivary glands
[45]. In mammary gland development and tumorigenesis
fibronectin is involved in motility and branching morpho-
genesis [6]. Fibronectin also participates in transmitting
Figure 2 Cytokine profile of U937-CM. A) Human ChemiArray™ Human Inflammation Antibody Array III (Chemicon) assessed 40 cytokines,
chemokines and growth factors, spots represent detected cytokines, chemokines and growth factors at different density levels. Detected low
secreted cytokines were: Eotaxin (E1,2), Eotaxin-2 (F1,2), GCSF(G1,2), GM-CSF (H1,2), ICAM-1(I1,2), IFN-g(J1,2), I-309 (K1,2), IL-1a (L1,2), IL-1b (A3,4), IL-2
(B3,4), IL-3(C3,4), IL-4 (D3,4), IL-6 (E3,4), IL-7 (G3,4), IL-8 (H3,4), IL-10 (I3,4), IL-11(J3,4), IL-12 p 40 (K3,4), IL-12 p 70 (L3,4), IL-13 (A5,6), IL-15 (B5,6), IL-16 (C5,6),
IL-17 (D5,6), IP-10 (E5,6), MCP-2 (G5,6), MIG (I5,6), MIP-1a (J5,6), MIP-1d (L5,6), TGF-b (B7,8), TNf-b (D7,8), s TNF RI (E7,8) and PDGF-BB (G7,8). Detected
moderately secreted cytokines were: IL-6 S R (f3, 4), M-CSF (H5, 6), MIP-1b (K5, 6), RANTES (A7,8), TNF-a (C7,8), s TNF RII (F7,8) and TIMP-2 (H7,8).
While, detected highly secreted cytokines were IL-8 (H3, 4) and MCP-1 (F5, 6). B) Bars represent dot intensities of the measured cytokines as
quantified by ImageJ software. Density values 0-4000 were considered as low secreted cytokines; 4000-8000 were considered as moderately
secreted cytokines, above 8000 were considered as highly secreted cytokines. Results were representatives of 3 independent experiments.
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carcinoma cells. For instance, interaction between a5b1-
integrin and fibronectin in T4-2 breast cancer cells is
essential for therapeutic response [46].
Elevated inflammatory cytokines circulating in cancer
patients stimulate the expression of adhesion molecules
which facilitate interactions between metastatic cells and
target organs [47]. Furthermore, interactions between
adhesion molecules and cues from inflammatory cells
within the tumor microenvironment plays a crucial role
in stimulating premalignant cells to undergo malignant
transformation, migration and dissemination of carci-
noma cells [31,48].
Three dimensional tissue culture models are reliable
tools to study IBC biology and interactions with inflam-
matory cells. For instance, SUM149 carcinoma cells
grown on 3D matrigel culture were able to maintain E-
cadherin expression essential for formation of emboli
like structure similar to IBC carcinoma recognized in
IBC xenograft models and IBC patients’ pathological
specimens [30]. Moreover, 3D culture allows cells to be
adhesive to basal lamina, which may indicate the prefer-
ence of IBC carcinoma cells to the connective tissue and
lymphatic fluid through which they disseminate [30].
Previous studies by the author and colleagues used 3D
culture showed that when SUM149 cells were directly
Figure 3 Expression of E-cadherin by SUM149 cells. A) Immunoblot analysis did not detect any difference in E-cadherin expression by
control SUM149 cells gown in complete culture media (lane a) versus those grown U937-CM (lane b), b-actin was used as loading control. B&
C) Immunostaining showed no difference in expression of E-cadherin (red) by SUM149 cells grown in complete culture media (B) versus SUM149
cells grown in U937-CM (C). While, SUM149 cells grown in U937-CM (C) migrate and form branched like structures. Nuclei were stained with
DAPI (blue) and scale bar = 10 μm. Results were representatives of 3 independent experiments.
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CM, SUM149 became more invasive and formed
branched like structures, a mechanism that was modu-
lated by an increase in proteolytic activity and caveolin-
1 expression of SUM149 [41]. The present study empha-
sized the reliability of 3D tissue culture models to study
the paracrine interaction between SUM149 and U937
cells. Herein, cytokines, chemokines and growth factors
secreted by U937 cells in the culture media were charac-
terized and their role in modulating the level of expres-
sion of adhesion molecules E-cadherin and fibronectin
by SUM149 cells in 3D models was identified. In the
present investigation U937 cells were found to secrete
different levels of inflammatory cytokines. IL-8 and
MCP-1 were the major highly secreted cytokines by
U937 cells. Inflammatory breast carcinoma SUM149
cells seeded in media conditioned by U937 cells dis-
played motile phenotype and formed branched like
structures associated with over-expression of adhesion
molecule fibronectin, whereas no alteration in the
expression of E-cadherin was detected.
Increases in the production of IL-8 and MCP-2 was
found to be associated with over-expression of fibronectin
by human proximal tubular HK-2 cells stimulated by
TGF-b1, a mechanism mediated by connective tissue
growth factor (CTGF) downstream signaling [49]. The
Figure 4 Expression of fibronectin by SUM149 cells. A) Immunoblot analysis revealed that fibronectin was weakly expressed by SUM149 cells
grown in complete media (lane a) and highly expressed by SUM149 cells grown in U937-CM (lane b), b-actin was used as loading control. B)
Immunostaining showed low expression of fibronectin (green) by SUM149 grown in complete culture media. C) SUM149 cells grown in U937-
CM migrate and form branched like structures highly express cellular and membranous fibronectin. Nuclei were stained with DAPI (blue) and
scale = 10 μm. Results were representatives of 3 independent experiments.
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Page 7 of 13Figure 5 IL-8 signaling pathway is involved in fibronectin production by SUM149 cells. A) Immunoblot analysis revealed that fibronectin
was weakly expressed by control SUM149 cells grown in complete media (lane a). On the other hand SUM149 cells grown in media
conditioned by MCP-1 and IL-8 highly express fibronectin (lanes b and c, respectively). Immunoblot analysis of PI3K-p85 revealed that control
SUM149 (lane a) and SUM149 treated with MCP-1 (lane b) weakly express PI3K-p85 while SUM149 cells treated with IL-8 showed high expression
of PI3K-p85. Phospho- and total Akt were analyzed by immunoblotting. Results revealed that control SUM149 (lane a) and SUM149 treated with
MCP-1 (lane b) weakly express p-Akt, while SUM149 cells treated with IL-8 characterized by more expression of p-AKT (lane c). Total Akt found to
be expressed by control SUM149 (lane a), SUM149 treated with MCP-1 (lane b) and SUM149 treated with IL-8 (lane c). B) Immunoblot analysis
showed no alteration in expression level of IL-8 specific receptors CXCR1 and CXCR2 by control SUM149 cells grown in complete media (lane a),
SUM149 cells treated with recombinant MCP-1 (lane b) and SUM149 cells treated with recombinant IL-8 (lane c). Mr. represents molecular weight
marker. Results were representatives of 3 independent experiments.
Mohamed Cell Communication and Signaling 2012, 10:3
http://www.biosignaling.com/content/10/1/3
Page 8 of 13present results disagree with Li and colleagues results
which found that media conditioned by U937 did not alter
expression of adhesion molecules E-cadherin or fibronec-
tin by HK-2 cells, while direct cell-cell interaction between
human proximal tubular HK-2 and U937 cells in mono-
layer culture induced EMT via up-regulation of intercellu-
lar adhesion molecule-1(ICAM-1), and fibronectin and
down-regulation of E-cadherin by HK-2 cells [50]. The dif-
ference between these results and the present results may
be due to different cell lines and tissue culture models
used. In the present study, we used 3D models that mimic
tumor microenvironment and allow cell-cell, cell-ECM
and cell-soluble mediators interactions.
The interaction of IL-8 with its specific receptors stimu-
lated the motility of highly metastatic human chondrosar-
coma cell line (JJ012) through PI3K/Akt signaling pathway
[43]. Interestingly, PI3K/Akt/mTOR signaling pathway
found to augment fibronectin expression by fibroblasts
[20]. The 3D cell-based assay is recommended to study the
role of fibronectin in morphogenesis and neoplasia of
human breast in-vitro culture models [6]. Increased expres-
sion of fibronectin mediates invasion and motility of color-
ectal cancer in-vitro culture [51] and is associated with
positive metastatic lymph nodes in-vivo [52]. In mammary
gland development and carcinogenesis fibronectin expres-
sion is associated with mammary cells transformation to
spindle like shape, motility and formation of branching like
structures [6]. The present study showed that cytokines,
chemokines and growth factors secreted by U937 induced
fibronectin expression and formation of branched like
structures by IBC cell line SUM149. Here, U937 secreted
cytokines, chemokines and growth factors induced
SUM149 motility and invasion without modulating E-cad-
herin expression. This supports the hypothesis that IBC
cells disseminate as clumps of cells adhered together by
adhesion molecule E-cadherin resulting in aggressiveness
of the disease [3] and suggests a role for fibronectin and IL-
8 signaling pathway in IBC invasion and dissemination.
Conclusions
The present study provides new information on the
interplay of monocytes and IBC cells in the process of
tumor emboli formation and spreading of IBC cells.
Moreover results indicated that IL-8 may enhance moti-
lity and spreading of IBC by increasing fibronectin
expression though PI3K/Akt signaling pathway.
Methods
Cell line and Reagents
IBC cell line SUM149 was a gift from Dr. Stephen P.
Ethier, Barbara Ann Karmanos Cancer Institute, Wayne
State University, Detroit, MI, USA. U937 human mono-
cytic cell lines [American Type Culture Collection
(ATCC, Manassas, USA], anti-CXCR2 and anti-CXCR2
polyclonal antibodies (From Thermo Scientific Pierce
Antibodies, IL. USA) were a gifts from Dr. Bonnie
Sloane’s lab, Department of Pharmacology, Wayne State
University, Detroit, MI, 48201, USA. Ham’sF - 1 2m e d i a
was purchased from Mediatech (Manassas, VA, USA).
Monoclonal mouse E-cadherin antibody and Dispase
was purchased from BD Biosciences, Inc. (San Diego,
CA, USA). Monoclonal anti-fibronectin antibody was
purchased from Sigma-Aldrich (St. Louis, MO, USA)
monoclonal anti-human fibronectin Antibody from
R&D Systems, Inc. (Minneapolis, MN, USA). PI3 Kinase
p85 (PI3K-p85) Antibody, Akt Antibody and phosphory-
lated Akt (p-Akt) were purchased from cell signaling
technology (Danvers, MA, USA). Fluorescein-conjugated
affinity-purified donkey anti-rabbit IgG and normal don-
key serum were purchased from Jackson ImmunoRe-
search (West Grove, PA, USA). ChemiArray™ Human
Inflammation Antibody Array III kit was from Chemi-
c o n( T e m e c u l a ,C A ,U S A ) .C u l t r e x
® Basement Mem-
brane Extract (BME) was from Trevigen (Gaithersberg,
MD, USA). Recombinant Human CCL2/JE/MCP1 and
Recombinant Human CXCL8/IL8 form R&D Systems
(Minneapolis, USA) were kind gift from Dr. Robert J.
Schneider’s lab, Department of Microbiology, New York
University, New York, NY, 10016, USA. Acrylamide and
nitrocellulose membranes we r ef r o mB i o R a d( H e r c u l e s ,
CA, USA). Horseradish peroxidase-labeled goat anti-
mouse IgG and Membrane peroxidase substrate 3, 3’,5 ,
5’ -Tetramethylbenzidine (TMB) were purchased from
Kirkegaard and Perry Laboratories (KPL), Inc. (Gaithers-
burg, MD, USA). Bradford Reagent for determining pro-
tein concentration was from Sigma (Sigma-Aldrich,
Germany). ProSieve
® Color Protein Marker was pur-
chased from Lonza (Cologne GmbH, Germany).
Culture of SUM149 cells in monolayer and 3D models
For monolayer culture assay, SUM149 cells at density of
250 × 10
3/ml were seeded on plastic Petri dishes in
Ham’s F-12 complete media and examined after 24 h,
48 h and 72 h by Zeiss Axiovert microscope (Carl Zeiss
AG, Germany). To examine cell morphological changes
on 3D culture, 30 mm Petri dishes were coated with
200 μl basement membrane extract BME (Culterx
®)
incubated at 37°C in CO2 incubator for 15 min till soli-
dification. Than SUM149 cells suspension at density of
250 × 10
3/ml was mixed with 2% BME overlaid on
coated Petri dishes as described before [41]. Cells on 3D
were examined microscopically after 24 h, 48 h and 72
h and morphological changes were inspected.
Preparation of human monocytes U937 conditioned
media (U937-CM)
Media conditioned by U937 cells secreted cytokines,
chemokines and growth factors (designated as U937-
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media for seeding of SUM149 were prepared as was
described before [53]. Briefly, U937 cells were seeded at
density of 2.5 × 10
5 cells/ml in Ham’sF 1 2c o m p l e t e
media into T-75 tissue culture flasks and grown to
approximately 80% confluency. Cells were collected
washed twice with phosphate-buffered saline (PBS) and
incubated overnight in serum-free medium. Overnight
condition media were collected and centrifuged at 700 g
at room temperature for 5 min to pellet cells. The
supernatant was collected and centrifuged at 2000 g at
4°C for 10 min to remove cell debris. The supernatant
representing U937-CM was divided into two aliquots
one subjected for cytokine profiling and the second ali-
quot was 5-fold concentrated using AmiconUltracell10K
filters (Millipore, Billerica, MA) for conditioning
SUM149 culture media.
Cytokine profiling of human monocytes U937-CM
One ml of serum free U937-CM was profiled using a
ChemiArray™ Human Inflammation Antibody Array III
kit that detects 40 different cytokines, chemokines and
growth factors. Method was conducted as was described
before [53]. Washing buffers and antibody dilutions
were provided with the kit and prepared as the kit
instruction guidelines. Antibody-array membrane was
placed in special tray provided with the kit followed by
addition of 1 ml blocking buffer for 30 min at room
temperature on a horizontal shaker followed by washing.
T h em e m b r a n ew a si n c u b a t e dw i t h1m lU 9 3 7 - C Ma n d
placed overnight at 4°C. After washing, the membrane
was incubated with primary antibody biotin-conjugated
anti-cytokines at room temperature for 2 h while shak-
ing. Washing and incubation with HRP-conjugated
streptavidin at room temperature was carried out for 2
h. After a final wash, the membrane signals were
detected by adding chemiluminescence detection
reagent provided with the kit and the membrane was
exposed to X-ray film for different time intervals. Signal
intensities representing fold differences between
detected cytokines were analyzed by imageJ software
(National Institutes of Health, MD, USA) as described
elsewhere [54]. Relative cytokines, chemokines and
growth factors levels were calculated by subtracting the
background staining and normalizing density value of
each cytokine, chemokine and growth factor spot to the
positive control spots on the same membrane. To com-
pare relative U937-CM detected cytokines, chemokines
and growth factors the density value detection limit was
divided into three ranges as follows: 0-4000 low secreted
cytokines; 4001-8000 moderately secreted cytokines and
above 8000 were considered as highly secreted
cytokines.
Utilizing 3D culture model to grow SUM149 cells in U937-
CM
Concentrated U937-CM prepared as described above
was diluted 1:5 with Ham’s F12 complete culture med-
ium containing 5% FBS then used as culture media for
SUM149 cells.
To prepare 3D culture model, 30 mm Petri dishes was
coated with 200 μl BME. Coated Petri dishes were incu-
bated at 37°C in CO2 incubator for 15 min to solidify.
SUM149 cell suspension at density of 250 × 10
3/ml was
mixed with 2% BME seeded as overlay culture over soli-
dified BME and left at CO2 incubator for 10-15 min till
cells stick as we described before [41]. Complete Ham’s
F-12 media were added and cells were incubated at 37°
Ci nC O 2 incubator. After 72 h, when SUM149 form
spheroid like structures, Ham’s F-12 complete media
containing 5% FBS was changed in the control Petri
dishes and replaced by media conditioned by U937-CM
in the tested Petri dishes. Culture media were discarded
after 48 h and SUM149 cells were washed several times
with PBS then serum free media were added and cells
were incubated at 37°C in CO2 incubator overnight.
Preparation of SUM149 cell lysates
Serums starved SUM149 cells grown as control and in
U937-CM were collected from BME by incubating them
in Dispase solution for 2 h at 37°C in humidified CO2
incubator to dissolve BME. Then the cell suspension
was transferred into a tube, mixed up and down several
times, followed by addition of EDTA to stop the action
of Dispase. Cells were centrifuged at 700 g and the pel-
let was washed several times and lysed in lysis buffer.
Cell lysates were sonicated on ice in a 50 W Ultrasoni-
cator five times for five seconds.
Sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) and immunoblot analysis
SDS-PAGE was conducted as described elsewhere [53].
Briefly, cell lysates were reduced and separated by SDS-
PAGE (12% acrylamide). Loading was performed at a
concentration of 30 μg protein per well. Gels were then
transferred onto nitrocellulose membranes. Immunoblot
analysis was performed with primary antibodies against
each of E-cadherin (1:2500), fibronectin (1:1000) and b-
actin (1:1000). Followed by washing, and the addition of
secondary antibody conjugated with horseradish peroxi-
dase (1:10,000) in Tris-buffered saline wash buffer (20
mM Tris, pH 7.5, 0.5 M NaCl) containing 0.5% Tween
20 and 5% (w/v) non-fat dry milk. After washing,
bounded antibodies were detected by adding TMB chro-
magen/substrate solution. Once the color was developed
the reaction was stopped by immersing the membrane
into water for 20-30 seconds.
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To localize and test expression of adhesion molecules E-
cadherin and fibronectin by control SUM149 cells cul-
tured in complete culture media in comparison to
SUM149 cells cultured in U937-CM, cells were seeded
in 24 well plates at density of 30 × 10
3 cell/well. Each
well was lined with a cover slip coated with 30 μlB M E .
After 72 h, cells were washed and media conditioned by
U937 secretions were added. Ham’sF - 1 2c o m p l e t e
media was added to the parallel wells as controls. After
48 h the cells were washed with PBS (37°C), and then
incubated overnight in serum free media. For immuno-
cytochemical staining, cells were fixed with -20°C
methanol for 5-10 min, at room temperature. Cells were
permeabilized with 2% saponin in PBS, blocking was
achieved by incubation with 0.5% bovine serum albumin
in PBS. E-cadherin and fibronectin staining was carried
out as previously described [55]. Primary antibodies
used were rabbit anti-human E-cadherin (1:50) and
fibronectin (1:50). Texas-Red-conjugated affinity-purified
donkey anti-mouse IgG (20 mg ml
-1) was used as sec-
ondary antibody. Negative control for immunocyto-
chemistry was run similarly but in the absence of
primary antibodies. Coverslips were mounted upside-
down with antifade reagent on super frost slides. Floure-
sence labeled cells were detected by Zeiss LSM 510 con-
focal microscope (Carl Zeiss, Thornwood, NY, USA).
Treatment of SUM149 cells with MCP-1 and IL-8
To study the role of individual cytokines MCP-1 and
IL-8 on fibronectin production and relevant down-
stream signaling pathway (PI3k/Akt/p-Akt) SUM149
cells were seeded in monolayer as described above.
After 72 h, when SUM149 form 70-80% confluence
complete culture media was replaced by serum free
media containing different concentrations of each of
recombinant MCP-1 and IL-8 (50, 100, 150 and 200
hg/ml). The results demonstrated that different con-
centrations of IL-8 and MCP-1 had similar effect on
the production of fibronectin by SUM149 cells (data
not shown). Thus, a dose of 200 hg/ml of recombinant
IL-8 and MCP-1 was selected as appropriate dose for
treatment. SUM149 cells were grown in BME in Ham’s
F12 complete medium containing 5% FBS as described
before. After 72 h, when SUM149 form spheroid like
structures, culture media was discarded, cells were
washed twice with PBS, cultured for 4 h in serum-free
media with each of recombinant IL-8 and MCP-1 (200
hg/ml). Cells were collected and prepared for SDS-
PAGE and immunoblot analysis of fibronectin, PI3k/
Akt/p-Akt and specific IL-8 receptors (CXCR1 and
CXCR2) as described above.
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